+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Reproducibility of measurements of estrogen receptor concentration in breast cancer



Reproducibility of measurements of estrogen receptor concentration in breast cancer



British Journal of Cancer 36(3): 355-361



The reproducibility of measurements of estrogen receptor activity was examined in multiple specimens from a rabbit uterus, a rat mammary tumor and human breast tumors. The relationship between receptor concentration and tumor histology was also investigated in 11 large primary tumors. In the animal tissues, receptor measurements were relatively reproducible (coefficient of variance [cv]: wet weight basis 16-17%, protein basis 16-21%) but in human breast tumors receptor activity varied considerably (c.v.: wet weight basis, 22-125%; protein basis, 28-72%). In addition to these variations in receptor activity within tumors, there was a difference between tumors, as demonstrated by an analysis of variance (P < 0.01). In the 11 primary breast cancers selected for study, the level of receptor activity was related to menopausal status and the tumor content of the specimen. The receptor activity detected varies within a tumor and depends on the tumor content of the biopsy specimen. Predictions based on precise quantitation of receptor concentrations may necessitate replicate tumor sampling and correction for the fraction of nontumor tissue in each sample.

(PDF emailed within 1 workday: $29.90)

Accession: 006315209

Download citation: RISBibTeXText

PMID: 200253


Related references

The use of anti estrogen receptor monoclonal antibodies in estrogen receptor measurements in human breast cancer. Anticancer Research 6(3 PART A): 381, 1986

Correlation of lactogenic receptor concentration in human breast cancer with estrogen receptor concentration. Cancer Research 44(5): 1963-1968, 1984

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta: regulation by selective estrogen receptor modulators and importance in breast cancer. Breast Cancer Research 2(5): 335-344, 2001

Interobserver reproducibility of immunocytochemical estrogen- and progesterone receptor status assessment in breast cancer. Anticancer Research 16(5a): 2497-2500, 1996

Estrogen and progesterone receptor assay in paraffin-embedded breast cancer--reproducibility of assessment. Acta Oncologica 42(1): 43-47, 2003

Increases in estrogen receptor-a concentration in breast cancer cells promote serine 118/104/106-independent AF-1 transactivation and growth in the absence of estrogen. The FASEB Journal 18(1): 93, 2004

Estrogen-dependent growth and estrogen receptor (ER)-alpha concentration in T47D breast cancer cells are inhibited by VACM-1, a cul 5 gene. Molecular and Cellular Biochemistry 301(1-2): 13-20, 2006

An estrogen receptor genetic polymorphism and a history of spontaneous abortion--correlation in women with estrogen receptor positive breast cancer but not in women with estrogen receptor negative breast cancer or in women without cancer. Breast Cancer Research and Treatment 26(2): 175-180, 1993

Increases in estrogen receptor-alpha concentration in breast cancer cells promote serine 118/104/106-independent AF-1 transactivation and growth in the absence of estrogen. Faseb Journal 18(1): 81-93, 2004

Do we still need estrogen and progesterone receptor measurements for breast cancer. Onkologie 20(5): 416-417, 1997

Treatment of estrogen-receptor positive breast cancer and estrogen-receptor negative breast cancer with retinoid with CH2 OH at the side chain terminal position. Official Gazette of the United States Patent & Trademark Office Patents 1240(3), Nov 21, 2000

Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Research 62(15): 4419-4426, 2002

Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling. Steroids 111: 113-120, 2017

Relationship between estrogen receptor concentration and cytomorphometry in breast cancer. Cancer 56(8): 1972-1976, 1985

Intra- and inter-laboratory reproducibility of estrogen and progesterone receptor enzyme immunoassay in breast cancer cytosol samples: A Swedish multicenter study. Acta Oncologica 36(8): 793-798, 1997